Patents by Inventor Mark Patrick Healy

Mark Patrick Healy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazine compounds
    Patent number: 6503909
    Abstract: A compound of formula (I) wherein R1 is phenyl substituted by one or more halogen atoms; R2 is —NH2; R3 is —NH2 or hydrogen; R4 is —CXNRaRb, —CXNH—(CH2)y—NRaRb; wherein X is ═O or +S; y is an integer zero, 1 or 2; Ra and Rb, which may be the same or different, are selected from hydrogen and C1-4 alkyl or together with the nitrogen atom to which they are attached form a saturated 5- or 6-membered heterocycle containing one or two nitrogen heteroatoms, which heterocycle can be further substituted with one or more C1-4 alkyl groups; and pharmaceutically acceptable derivatives thereof.
    Type: Grant
    Filed: February 8, 2001
    Date of Patent: January 7, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Brian Cox, Mark Patrick Healy, Deborah Wild
  • Triazine compounds for treatment of CNS disorders
    Patent number: 6465461
    Abstract: A compound of formula (I) and pharmaceutically acceptable prodrugs, salts and solvates thereof.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: October 15, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Brian Cox, Mark Patrick Healy, Malcolm Stuart Nobbs, Gita Punjabhai Shah
  • Triazine compounds for treatment of CNS disorders
    Patent number: 6265405
    Abstract: A compound of formula (I) and pharmaceutically acceptable prodrugs, salts and solvates thereof.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: July 24, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Brian Cox, Mark Patrick Healy, Malcolm Stuart Nobbs, Gita Punjabhai Shah